Otsuka Pharmaceutical Settles Patent Lawsuit With Sawai Over Rebamipide
This article was originally published in PharmAsia News
Executive Summary
Japan's largest generic drug maker Sawai Pharmaceutical announced Oct. 15 it settled a patent lawsuit with Otsuka Pharmaceutical over gastroprotective agent rebamipide